270 related articles for article (PubMed ID: 30945774)
1. Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies.
Svaren J; Moran JJ; Wu X; Zuccarino R; Bacon C; Bai Y; Ramesh R; Gutmann L; Anderson DM; Pavelec D; Shy ME
Ann Neurol; 2019 Jun; 85(6):887-898. PubMed ID: 30945774
[TBL] [Abstract][Full Text] [Related]
2. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
4. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
6. PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.
Nobbio L; Visigalli D; Radice D; Fiorina E; Solari A; Lauria G; Reilly MM; Santoro L; Schenone A; Pareyson D;
Brain; 2014 Jun; 137(Pt 6):1614-20. PubMed ID: 24812204
[TBL] [Abstract][Full Text] [Related]
7. PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
Zhao HT; Damle S; Ikeda-Lee K; Kuntz S; Li J; Mohan A; Kim A; Hung G; Scheideler MA; Scherer SS; Svaren J; Swayze EE; Kordasiewicz HB
J Clin Invest; 2018 Jan; 128(1):359-368. PubMed ID: 29202483
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
9. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
Hanemann CO; Gabreëls-Fasten AA; Müller HW; Stoll G
Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
[TBL] [Abstract][Full Text] [Related]
10. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients.
Hanemann CO; Rosenbaum C; Kupfer S; Wosch S; Stoegbauer F; Müller HW
Glia; 1998 Jun; 23(2):89-98. PubMed ID: 9600378
[TBL] [Abstract][Full Text] [Related]
11. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
[TBL] [Abstract][Full Text] [Related]
12. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
[TBL] [Abstract][Full Text] [Related]
13. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
14. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
Stavrou M; Kagiava A; Choudury SG; Jennings MJ; Wallace LM; Fowler AM; Heslegrave A; Richter J; Tryfonos C; Christodoulou C; Zetterberg H; Horvath R; Harper SQ; Kleopa KA
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35579942
[TBL] [Abstract][Full Text] [Related]
15. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
[TBL] [Abstract][Full Text] [Related]
16. P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy.
Nobbio L; Sturla L; Fiorese F; Usai C; Basile G; Moreschi I; Benvenuto F; Zocchi E; De Flora A; Schenone A; Bruzzone S
J Biol Chem; 2009 Aug; 284(34):23146-58. PubMed ID: 19546221
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
18. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
[TBL] [Abstract][Full Text] [Related]
19. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
20. AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A.
Gautier B; Hajjar H; Soares S; Berthelot J; Deck M; Abbou S; Campbell G; Ceprian M; Gonzalez S; Fovet CM; Schütza V; Jouvenel A; Rivat C; Zerah M; François V; Le Guiner C; Aubourg P; Fledrich R; Tricaud N
Nat Commun; 2021 Apr; 12(1):2356. PubMed ID: 33883545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
